Compare ZLAB & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | KN |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 2017 | 2013 |
| Metric | ZLAB | KN |
|---|---|---|
| Price | $26.25 | $35.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $49.60 | $28.00 |
| AVG Volume (30 Days) | ★ 1.2M | 708.3K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.46 | ★ 118.94 |
| EPS | N/A | ★ 0.11 |
| Revenue | $460,156,000.00 | ★ $593,200,000.00 |
| Revenue This Year | $9.75 | $9.40 |
| Revenue Next Year | $26.03 | $6.98 |
| P/E Ratio | ★ N/A | $322.64 |
| Revenue Growth | ★ 15.33 | 7.17 |
| 52 Week Low | $15.96 | $20.57 |
| 52 Week High | $34.72 | $42.93 |
| Indicator | ZLAB | KN |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 48.78 |
| Support Level | $16.98 | $33.72 |
| Resistance Level | $27.08 | $40.03 |
| Average True Range (ATR) | 0.84 | 1.04 |
| MACD | -0.19 | 0.13 |
| Stochastic Oscillator | 53.72 | 73.93 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.